Answer:
and 
Explanation:
Our goal for this question is the calculation of the number of moles of the molecules produced by the reaction of hydrazine (
) and <u>oxygen</u> (
). So, we can start with the <u>reaction</u> between these compounds:
Now we can <u>balance the reaction</u>:
In the problem, we have the values for both reagents. Therefore we have to <u>calculate the limiting reagent</u>. Our first step, is to calculate the moles of each compound using the <u>molar masses values</u> (32.04 g/mol for
and 31.99 g/mol for
):


In the balanced reaction we have 1 mol for each reagent (the numbers in front of
and
are 1). Therefore the <u>smallest value would be the limiting reagent</u>, in this case, the limiting reagent is
.
With this in mind, we can calculate the number of moles for each product. In the case of
we have a <u>1:1 molar ratio</u> (1 mol of
is produced by 1 mol of
), so:

We can follow the same logic for the other compound. In the case of
we have a <u>1:2 molar ratio</u> (2 mol of
is produced by 1 mol of
), so:

I hope it helps!
Answer:
secondary, because there are some remains of the previous community (C)
Explanation:
True
Im happy i could help you today
have a great rest of ur week :)
Answer: Option (A) is the correct answer.
Explanation:
Chemical equation for the given reaction is as follows.

And, the expression to calculate pH of this reaction is as follows.
pH = ![pk_{a} + log \frac{[HCOO^{-}]}{[HCOOH]}](https://tex.z-dn.net/?f=pk_%7Ba%7D%20%2B%20log%20%5Cfrac%7B%5BHCOO%5E%7B-%7D%5D%7D%7B%5BHCOOH%5D%7D)
As the concentration of
is directly proportional to pH. Hence, when there occurs a decrease in the pH of the solution the
will also decrease.
Thus, we can conclude that the statement, HCOO will accept a proton from HCl to produce more HCOOH and
, best supports the student's claim.
Answer:
See explanation
Explanation:
The drug thalidomide with molecular formula C13H10N2O4 was widely prescribed by doctors for morning sickness in pregnant women in the 1960s.
The drug was sold as a racemic mixture (+)(R)-thalidomide and (-)(S)-thalidomide.
Unfortunately, only the (+)(R)-thalidomide exhibited the required effect while (-)(S)-thalidomide is a teratogen.
This goes a long way to underscore the importance of separation of enantiomers in drug production.
Therefore, all the teratogenic effects observed when using the drug thalidomide was actually as a result of the presence of (-)(S)-thalidomide, the unwanted enantiomer.